BRAF May Be a Good 'Target' in Nonmelanoma CancersBRAF May Be a Good 'Target' in Nonmelanoma Cancers
Early findings from a 'basket study' suggest that BRAF V600 may be a targetable oncogene in malignancies other than melanoma. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | Melanoma | Nonmelanoma Skin Cancer | Skin Cancer | Study